Sign up for Table of Contents Alerts.

Email this page

Print this page

Perspectives

Extracellular HSP90: Conquering the cell surface

Katerina Sidera and Evangelia Patsavoudi

Purchase article for $19

Subscribe to this journal for $129/year

Heat shock protein 90 (HSP90) is a highly conserved molecular chaperone, assisting intracellularly in the folding and conformational regulation of a multitude of client proteins that play a crucial role in growth, cell survival and developmental processes(1). Moreover HSP90 interacts with a great number of molecules that are involved in the development and/or survival of cancer cells, allowing mutant proteins to retain or gain function while permitting cancer cells to tolerate the imbalanced signaling that such oncoproteins create (2,3). Prime examples include the HER-2 receptor, c-Raf-1, Akt/PKB, CDK4, and mutant p53 (4,5). Highly specific inhibitors of HSP90 have been identified and are currently under clinical evaluation. These include geldanamycin and its derivatives 17-allylamino-17-demethoxygeldanamycin and 17-dimethylaminoethylamino-17-demethoxygeldanamycin, which inhibit cancer cell proliferation in vitro and tumor growth in vivo (6-9).

Authors

Katerina Sidera

Hellenic Pasteur Institute; Athens, Greece

Evangelia Patsavoudi

Hellenic Pasteur Institute; Athens, Greece

Purchase article for $19

Subscribe to this journal for $129/year